Schobel Alexander Mark
- SEC CIK
- 0001406836
No open-market purchases or sales filed in the past year.
Current role at each company
- AQST Aquestive Therapeutics, Inc.Chief Innovation/Tech Officeras of Oct 2, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Schobel Alexander Mark as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 19, 2024 (view filing) | Mar 15 | 4 days | Schobel Alexander MarkChief Innovation/Tech Officer | SSale | −50.0K | $6.00 | −$300.0K | −4.8%984.5K after | 10b5-1 |
| Mar 12, 2024 (view filing) | Mar 8 | 4 days | Schobel Alexander MarkChief Innovation/Tech Officer | SSale | −25.0K | $5.19 | −$129.8K | −2.3%1.04M after | From original |
| Jun 10, 2022 (view filing)5:26 PM ET | Jun 8 | 2 days | Schobel Alexander MarkChief Innovation/Tech Officer | PPurchase | +45.9K | $0.96 | +$44.0K | +5.5%882.9K after | |
| Jun 10, 2022 (view filing)5:26 PM ET | Jun 8 | 2 days | Schobel Alexander MarkChief Innovation/Tech Officer | PPurchase | +45.9K | $0.13 | +$5.96K | –45.9K after | Derivative |